X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-11 | HARP | Merck & Co., Inc. | 10% | P - Purchase | $23.00 | +21,397,205 | 1,000 | -100% | +$492,135,715 | ||||||
D | 2023-10-25 | HARP | New Leaf Biopharma Opportunities Ii, L.P. | 10% | P - Purchase | $0.00 | +1,543,500 | 1,869,169 | +474% | +$0 | |||||
D | 2023-10-25 | HARP | Hunt Ronald | Dir, 10% | P - Purchase | $0.00 | +1,543,500 | 412,512 | -136% | +$0 | |||||
D | 2023-03-23 | HARP | Hunt Ronald | Dir, 10% | P - Purchase | $1,000.00 | +10,000 | 3,166,699 | 0% | +$10,000,000 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |